- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT07921407
Clinical and 3D Evaluation of Injectable Versus Conventional Composite in Class V Restorations
Clinical Assessment and 3D Evaluation of Surface Properties and Periodontal Response of Injectable Bioactive Resin Composite Versus Conventional Resin Composite in Restoration of Class V Cavities: Randomized Clinical Trial
The study aims to clinically assess the surface finish and periodontal response of injectable resin composite vs conventional resin composite in class V restorations and reevaluate after six months follow u. It is aim to answer which composite has no change in periodontal response, superior marginal integrity surface texture. Researcher will compare the two composites, and the participants will have the restorations in class V and get a follow up after 6 months.
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Patients presenting with Class V cervical cavities requiring restoration.
- Age range ( ≥18 years).
- Teeth with vital pulp.
- Patients with acceptable oral hygiene and willingness to participate and attend follow-up visits.
Exclusion Criteria:
- Patients with systemic diseases affecting periodontal health or healing.
- Poor oral hygiene or active periodontal disease.
- Non-vital teeth or teeth with periapical pathology.
- Severe parafunctional habits.
- Allergy to resin-based materials.
- Pregnant or lactating women.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Active Comparator: Packable nano-hybrid composite
|
Bioactive, injectable composite |
|
Experimental: Bioactive injectable composite
|
Bioactive, injectable composite |
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Color change
Time Frame: At baseline after 3 months after 6 months
|
Color change of the restorations will be clinically evaluated using FDI criteria by calibrated examiner. |
At baseline after 3 months after 6 months
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start (Estimated)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- CONS-3-3-5
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.